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Abstract
Background: The Surviving Sepsis Campaign (SSC) guidelines describe best practice for the management of severe sepsis
and septic shock in developed countries, but most deaths from sepsis occur where healthcare is not sufficiently resourced
to implement them. Our objective was to define the feasibility and basis for modified guidelines in a resource-restricted
setting.
Methods and Findings: We undertook a detailed assessment of sepsis management in a prospective cohort of patients with
severe sepsis caused by a single pathogen in a 1,100-bed hospital in lower-middle income Thailand. We compared their
management with the SSC guidelines to identify care bundles based on existing capabilities or additional activities that
could be undertaken at zero or low cost. We identified 72 patients with severe sepsis or septic shock associated with S.
aureus bacteraemia, 38 (53%) of who died within 28 days. One third of patients were treated in intensive care units (ICUs).
Numerous interventions described by the SSC guidelines fell within existing capabilities, but their implementation was
highly variable. Care available to patients on general wards covered the fundamental principles of sepsis management,
including non-invasive patient monitoring, antimicrobial administration and intravenous fluid resuscitation. We described
two additive care bundles, one for general wards and the second for ICUs, that if consistently performed would be predicted
to improve outcome from severe sepsis.
Conclusion: It is feasible to implement modified sepsis guidelines that are scaled to resource availability, and that could
save lives prior to the publication of international guidelines for developing countries.
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Introduction
Sepsis is the systemic inflammatory response to infection [1,2].
Severe sepsis and septic shock are estimated to affect millions of
people each year and are important causes of mortality
worldwide [3,4,5,6]. The Surviving Sepsis Campaign (SSC)
guidelines first published in 2004 [7] and updated in 2008 [8]
are highly influential documents that describe best practice for
the management of sepsis in resource-rich settings, and represent
a milestone in the improvement of clinical care standards in the
developed world. However, the majority of sepsis deaths
worldwide occur in the developing world, where bacterial
infections are implicated as the direct cause of death from lower
respiratory tract infections, meningitis, and a range of other
infections [9,10,11,12] and also complicate other common
diseases such as malaria, HIV/AIDS and diabetes mellitus
[13,14,15]. Severe sepsis in resource-limited low- and middle-
income countries is understudied but is associated with extremely
high mortality rates [16,17,18,19], yet with the exception of
recent pandemic influenza guidelines [20] no recommendations
exist that detail effective approaches to sepsis care in these
settings [21].
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e29858The facilities and therapeutics available for the management of
patients with sepsis beyond the developed world are highly
variable and form a wide spectrum of capabilities, including a
developing intensive care service in many under-resourced
healthcare settings [22]. We have proposed previously that
modified guidelines are required to promote a scaled approach
to management based on optimal utilisation of existing resources
[23]. Here, we describe a prospective observational study of
patients with severe sepsis treated at a hospital in provincial,
northeast Thailand where the SSC guidelines have not been
implemented because of resource limitations. We determined the
extent to which these guidelines are already incorporated into
patient care, identified the range of variability in their application,
and designed achievable care bundles consisting of activities that
could be implemented within available capabilities resources and
without delay.
Methods
Ethical statement
The Ethics Committee of the Ministry of Public Health, Royal
Government of Thailand and the Oxford Tropical Research
Ethics Committee approved the study.
Setting and facilities
Sappasithiprasong Hospital is situated in the provincial town of
Ubon Ratchathani in northeast Thailand, 70 km west of Laos and
95 km north of Cambodia. This 1,100-bed hospital serves around
2 million people, the majority of whom are rice farmers. Facilities
include diagnostic laboratory and radiology services including a
CT scanner. General medical, surgical and orthopaedic wards are
mainly open-plan with around 30 beds per ward, increasing to 60
beds per ward in response to demand. There are 13 separate
intensive care units (ICU) (four paediatric and nine adult), each
containing between eight and 14 beds. Piped oxygen is available in
each ICU for all beds, along with bedside monitoring for oxygen
saturations. On the general wards, oxygen is piped to the half of
the ward closest to the nurses’ area, with tanks of oxygen available
for the remainder of the beds. Bedside monitoring for oxygen
saturations is available for four to five beds per general ward, with
one to two portable pulse oximeters available per ward for the
remainder. Full blood count, renal and liver function tests, plasma
glucose and coagulation tests are available, while plasma lactate,
plasma C-reactive protein and procalcitonin are not available.
Disposable peripheral intravenous devices are available through-
out the hospital. Red blood cell transfusions are obtainable, but
supplies are limited and family members may be expected to
donate blood to facilitate transfusions, particularly with uncom-
mon blood groups. Use of standard central venous devices is
limited to ICUs, with the use of cut-downs inserted at the
antecubital fossa for central venous access in general wards.
Electrically powered multi-function ventilators (e.g. Bear Cub,
Infant Star, or Bennett) are available in ICUs, while patients on
general wards may be ventilated by older gas driven ventilators
(Bird Mark 7). Haemofiltration machines are available but
generally restricted to treatment of patients with chronic renal
failure because of limited resources. All of the major classes of
parenteral antimicrobial agents are available including the
carbapenems. The registered nurse-to-patient ratio is approxi-
mately 1:8 on general wards and 1:2.5–3.5 on ICUs. The
workload of attending physicians is extremely high and timing of
attendance to new and existing patients is prioritised based on an
assessment of severity of illness made by healthcare attendants,
including medical students and interns.
Patient recruitment
Our objective was to identify patients with severe sepsis due to a
single, common human pathogen, and chose Staphylococcus aureus as
it represents a global pathogen and is the third most common
blood culture isolate at Sappasithiprasong Hospital (after Burk-
holderia pseudomallei and Escherichia coli). All patients with one or
more clinically significant blood cultures positive for S. aureus were
identified over a period of one year (November 2006 to November
2007). Cases were identified each day at the diagnostic
microbiology laboratory, followed by same day ward visit. Patients
were recruited after obtaining written informed consent and
visited daily until discharge. Detailed clinical information
including patient management was recorded from the patient
chart using standardised forms for the three day period starting
from the day the first culture positive for S. aureus was taken (to
reflect the 72 hours of early goal-directed therapy for sepsis
described by Rivers et al) [24]. Outcome (survival or death) was
defined 28 days after the first positive culture was taken, with
phone call follow up for those patients discharged from hospital
alive. The cases described here represent a subset of a larger
cohort reported previously [25,26].
Defining sepsis
Children were defined as 18 years of age or less to be consistent
with the paediatric sepsis classification [27] (patients aged 14 years
or more are treated on adult wards in our setting). Data from the
first 24 hours after the first positive culture was taken were used to
categorise patients as having sepsis, severe sepsis and septic shock.
Published definitions of sepsis [1,2,27] were used, as follows: (i)
sepsis was defined as systemic inflammatory response syndrome
(SIRS) associated with infection; (ii) severe sepsis was SIRS with
organ dysfunction, arterial hypotension, or tissue hypoperfusion as
denoted by acidosis or clinical signs; (iii) septic shock was SIRS
with arterial hypotension. Defining septic shock as hypotension
despite adequate fluid resuscitation was not possible because
recording of fluid volumes given to study patients was incomplete.
Diagnostic criteria for organ dysfunction were modified from the
SSC guidelines to classify patients based on available data
(Table 1).
Evaluation of sepsis management
The details of patient management during the three days after
the first positive culture was taken were recorded with particular
reference to table 3 (initial resuscitation and infection issues), table
4 (haemodynamic support and adjunctive therapy), and table 5
(other supportive therapy of severe sepsis) contained within the
2008 SSC Campaign guidelines [8]. Recommended activities that
were undertaken during routine clinical care in our hospital were
noted, together with the proportion of patients who received each
activity. Using these data, we then designed a sepsis management
programme based on activities that were already part of routine
care, together with activities that were not routine that fell within
existing resources or could be implemented at zero or very low
additional cost. We described two care bundles, one for use on
general wards (bundle I) and the second for use on intensive care
units (bundle II).
Results
Identification of patients with severe sepsis
We identified a total of 106 eligible patients with S. aureus
bacteraemia, of whom 98 were recruited (Figure 1). Of the 98
evaluable patients, 57 (58%) were male, and age ranged from one
day to 92 years (median 39 years, interquartile range 9 to 65
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documented in 57 cases (58%), with cardiac disease accounting for
the greatest proportion (19 cases, 19%). An identified site of
infection (beyond bacteraemia) was found in 59 patients (60%).
Methicillin-resistant S. aureus (MRSA) was responsible for infection
in 27 patients (28%). Vital signs and full blood count were
performed in every patient. From this we determined that 88 of
the 98 patients (90%) with S. aureus bacteraemia met the criteria for
sepsis within the three day period starting on the day that the
positive blood culture was taken. Of these 88 patients, 72 (49
adults) had severe sepsis, including a subset of 48 patients (31
adults) with septic shock.
Management of 72 patients with severe sepsis
Of the 72 patients with severe sepsis, 28 patients (14/23
children [61%] and 14/49 adults [29%]) received care in an ICU
and the remainder were treated on a general ward. The adult
ICUs ran at full occupancy during the study period and access was
strongly influenced by bed availability. Their sepsis management is
summarised in Table 2. The 28 day mortality rate was 53% (38/
72 patients), and half of the patients who died did so within 3 days
after the day the first culture positive for S. aureus was taken. The
mortality for patients with septic shock was 60% (29/48 patients)
versus 38% (9/24 patients) for those not in septic shock; and the
mortality for patients cared for in an ICU was 61% (17/28
patients) versus 48% (21/44 patients) for general ward based care.
The timing of severe sepsis recognition and initial resuscitation
measures were variably documented in patient records. Crystalloid
was used as initial fluid resuscitation in all cases, and a blood
pressure of 90/60 mmHg was generally used as a goal of the
resuscitation. Fluid challenges were documented in 19 patients
(26%), all of whom had septic shock. The initial challenge volume
ranged from 150 to 250 mls. The total volumes of fluid infused
were not recorded. A central venous device was placed in 12
patients (17%; 8 were cut-downs), of whom 6 patients (all with
septic shock) had central venous pressure (CVP) documented.
Invasive monitoring of arterial pressure via an intra-arterial
catheter was only possible in the cardiothoracic wards, and was
not performed on any of the 5 study patients on this ward. A
urinary catheter was inserted in 37 patients (51%), and urinary
output was recorded in 43 patients (60%). Study eligibility criteria
meant that all study patients had at least one blood culture taken;
$2 blood cultures were taken from 10 patients (14%) during initial
assessment. The majority of patients (86%) underwent radiological
imaging, with 55 patients (76%) having a chest radiograph, 15
patients (21%) an ultrasound or Doppler scan, and 8 patients
(11%) a computed tomography (CT) scan.
A broad-spectrum intravenous antibiotic was received by 68
patients (94%) within 24 hours after the first positive blood culture
was taken, although the time of administration of the first
antibiotic dose was not recorded. The infecting isolate was
susceptible to the empiric antimicrobial drug used in 53 cases,
but not in 15 cases (all infected with MRSA). Once culture results
were available, almost all patients who were still alive (48 out of 49,
98%) received an antibiotic that covered their infecting isolate of S.
aureus. A specific anatomical site of infection was identified in 46
patients, of whom 15 patients had a procedure contributing to
infectious source control (abscess drainage 6, debridement 5, joint
wash-out 1, fasciotomy 1, above knee amputation 1, chest drain
insertion 1). A further 5 patients had a potentially drainable
collection of pus identified or infected prosthetic material but did
not undergo a procedure as this was deemed unfeasible because of
the presence of a coagulopathy, or clinical instability that
prevented movement of the patient to another department.
One or more vasoactive drugs were used in 26 out of 48 patients
with septic shock (54%), dopamine being used most often as the
first line agent. The majority of patients prescribed vasopressors or
inotropes (65%) received the drug through a peripheral intrave-
nous catheter. Steroids were not used in the management of sepsis,
and recombinant human activated protein C (rhAPC) was not
available. Red blood cell transfusions were given in 7 of 10 patients
(70%) with haemoglobin less than 7.0 g/dl, and were targeted to
reach a haemoglobin of $9 mg/dl.
Supplemental oxygen was given to 39 patients (54%), of whom
11 (28%) were monitored by arterial blood gases and 15 (35%) had
at least one oxygen saturation result recorded in their notes.
Specific data on levels of hypoxaemia were not recorded as part of
the study, and it was not possible to calculate the inspired fraction
of oxygen as oxygen delivery was not controlled/quantified. A
total of 36 patients (50%) were ventilated. The Bird Mark 7 model
was used to ventilate 22 patients (16 on general wards and 6 in
ICUs), of whom 2 (9%) survived (both in an ICU). Electrically
powered mechanical ventilators were used in 14 patients (all in
ICUs), of whom 4 (29%) survived. Sedation was variably given to
ventilated children, but was not routine for ventilated adults.
Glucose control was achieved by intermittent point-of-care
testing of capillary blood glucose and subcutaneous insulin. None
of the 18 patients with acute renal failure or an additional 15
patients who were acidotic received dialysis. No patients received
deep vein thrombosis or stress ulcer prophylaxis.
Modified care bundles for severe sepsis management
Based on resources available to us together with information
from the published literature, we devised two incremental care
bundles for patients presenting with suspected infection in our
setting (Table 3, 4 and 5). Bundle I is for use on general wards and
includes interventions that are already performed in some cases
but that could be implemented in all cases using available
Table 1. Diagnostic criteria used for organ dysfunction.
Organ system Organ dysfunction variables
Kidney Acute oliguria
Urine output ,500 ml per 24 hrs or
,12 ml/kg per 24 hrs in paediatric patients
Azotaemia
Creatinine .2 mg/dl (177 mmol/l) or
.2 times upper limit of normal for age
Haematologic Thrombocytopaenia
Platelets ,100610
9/l or
,80610
9/l in paediatric patients
Liver Hyperbilirubinaemia
.2 mg/dl (34.2 mmol/l) in adults, or .4 mg/dl (except
newborns),or ALT .2 times upper limit of normal for age
in paediatric patients
Respiratory Mechanical ventilation
Cardiovascular Arterial hypotension
SBP ,90 mmHg, or ,age-specific BP in paediatric
patients (septic shock), or use of vasoactive drugs
(dopamine only .5 mg/kg/min)
Criteria were from the literature [1,2,27] to fit the available data. Acute oliguria
was determined from 24-hour urine because hourly urine output was
infrequently monitored. Diagnostic criteria of arterial hypoxaemia (PaO2/
FiO2,300), ileus, and clinical signs of tissue hypoperfusion (decrease capillary
refill or mottling) were not used as data were not recorded in the patient
records. Laboratory testing for lactate level was not available in the hospital.
The Glasgow Coma Score was not documented in patient records.
doi:10.1371/journal.pone.0029858.t001
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modest increase in costs. Central to the diagnosis of severe sepsis is
assessment of organ dysfunction. This can be accomplished by
expanding the clinical assessment of the patient with suspected
infection (evaluating and recording Glasgow Coma Scores,
capillary refill (in children), calculating PaO2 or SpO2 and
inspired oxygen levels for those on supplemental oxygen) and
measuring serum creatinine and bilirubin in addition to the full
Figure 1. Study flow diagram.
doi:10.1371/journal.pone.0029858.g001
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administration of antibiotics within 1 hour of recognition of sepsis,
and provision of adequate volumes of intravenous fluid with
respiratory/haemodynamic support to maintain tissue oxygen
delivery, using an iterative resuscitation strategy. Point of care
lactate measurement is a simple and useful tool both to diagnose
and manage severe sepsis that is not readily available currently but
that we propose is a worthwhile investment [29,30]. Bundle II
includes a combination of ICU-specific interventions that require
no additional resources and that could be implemented immedi-
ately (e.g. PEEP in mechanically ventilated patients with
respiratory failure), and those with cost implications (e.g.
haemodialysis).
Discussion
This study of severe staphylococcal sepsis is among the first to
quantify the management and outcome of patients with sepsis
admitted to a large district general hospital in a lower-middle
income country. We consider it highly likely that our facilities and
care provision parallels that of many hospitals throughout the
world. Existing capabilities were such that the fundamental
principles of sepsis management could be achieved, but the
current SSC guidelines were not implementable. The need for
feasible sepsis management guidelines was clearly demonstrated by
the mortality rate of 53% of patients in this study. This contrasts
with a mortality rate of 20–29% for septic patients with
hypoperfusion or organ dysfunction in the US [31,32], and 33–
52% for severe sepsis patients in Brazil [17]. This prompted us to
develop two modified sepsis care bundles. Bundle I focuses on care
that is not routine but that can be accomplished with little
additional cost and could be implemented even in general ward
settings, whereas Bundle II is ICU-specific and the interventions
may be more expensive. Extrapolating from published data in high
resource settings, the adoption of these bundles would be predicted
to be associated with a significant increase in patient survival
[33,34].
Early detection of severe sepsis could be one of the major keys to
reducing the high mortality rate of severe sepsis in developing
countries. We found that nearly all methods to detect severe sepsis
are available in our setting, and could be performed more
consistently in patients with suspected infection. As summarised in
care bundle I, to capture the organ dysfunction indicative of severe
sepsis requires simple additional clinical assessments and routine
measures of serum creatinine and bilirubin in addition to the full
blood count. We suggest that addition of point-of-care lactate level
would be safe, inexpensive and very beneficial to early detection of
severe sepsis in our setting.
Many of the existing recommendations for treatment of severe
sepsis could also be implemented with little additional expense. We
found that the hospital is fully equipped with all material resources
required for the fundamentals of sepsis management, including
microbiological investigation, fluid resuscitation, antimicrobial
drugs, and vasoactive agents. Bundle I specifies many of these
interventions, while bundle 2 recognised areas of improvement
relating to more complex sepsis management therapies in the ICU
such as invasive haemodynamic monitoring, ventilation and
dialysis, where variability in practice may relate to a combination
of lack of guidelines and resource management. For example,
haemodialysis was available but reserved for patients with chronic
renal failure, and reassessment of the utilisation of this treatment
modality could result in the provision of equipment for a limited
number of patients with acute renal failure. Evidence supports the
use of haemodialysis for sepsis-related renal failure in low resource
settings [35].
Mechanical ventilation also deserves careful consideration.
Physicians are often reticent to use currently recommended fluid
challenge volumes for fear of fluid overload in the absence of
respiratory support, but respiratory failure may in fact be due to
Table 2. Management and outcome of 72 patients with
severe sepsis.
Number of
patients (%)
Place of care
ICU 28 (39%)
General wards 44 (61%)
Fluid resuscitation
Use of crystalloid fluid 72 (100%)
Documented fluid bolus 19 (26%)
Monitor and goal of fluid resuscitation
Record fluid balance 52 (72%)
Urinary catheterisation 37 (51%)
Central venous access 12 (17%)
Record CVP 6 (8%)
Antibiotic therapy
Broad-spectrum intravenous
antibiotic before culture result
68 (94%)
Broad-spectrum intravenous antibiotic
effective against infecting organism
53/68 (78%)
Effective antibiotic given after culture result 48/49 (98%)
Source identification and control
Any radiological imaging 62 (86%)
Chest radiography 55 (76%)
Identify anatomical site of infection 46 (64%)
Use procedure to control infectious
source where applicable
15/15 (100%)
Respiratory support
Supplementary oxygen if not ventilated 20/36 (55%)
Mechanical ventilation 36 (50%)
Monitor oxygen level
With oxygen saturation alone 26 (36%)
With arterial blood gas (at least one value) 15 (21%)
Vasopressor and inotropic therapy
Vasoactive drug use in patients with septic shock 26/48 (54%)
Dobutamine use in patients with septic shock 7/48 (15%)
Other support
Blood product administration in patients
with haemoglobin less than 7.0 g/dl
7/10 (70%)
Subcutaneous insulin to control hyperglycaemia 8 (11%)
Outcome
28 day mortality 38 (53%)
28 day mortality in subset with septic shock 29/48 (60%)
28 day mortality in subset managed on ICU 17/28 (61%)
28 day mortality in subset managed
on general ward
21/44 (48%)
When not shown the patient denominator is 72. Where the denominator differs
from this for a particular question, these are shown.
doi:10.1371/journal.pone.0029858.t002
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patients on a general ward using a Bird Mark 7 model was not
associated with a survival benefit (all 16 patients died). These
patients were not sedated, and the process by which the efficiency
of ventilation was monitored was sub-optimal. This requires an
evaluation to either improve ventilation protocol in general wards,
or limit the use of ventilators to an ICU setting.
Invasive haemodynamic monitoring is performed routinely in
high resource settings but central venous catheters carry
mechanical, thrombotic, and infectious complications [36].
Furthermore, how well such catheters indicate adequacy of
resuscitation is subject to debate. Thus the balance of benefit
versus risk needs to be addressed for each patient in low resource
settings. The finding that serial lactate measures are a suitable
alternative to ScvO2 monitoring in sepsis management [30]
provides additional support for use of point-of-care lactate testing,
perhaps in place of targeting a goal of central venous catheter
placement in all patients with severe sepsis.
We understand the limitation of human resources versus the
time required to implement the recommendations of the bundles
described by this study, which could represent high additional
cost if more nurses and doctors are required. However, if early
detection and early management of sepsis is aggressively
undertaken, fewer invasive and time consuming interventions
such as haemodialysis and mechanical ventilation due to multiple
organ failure will be required. In addition, more lives can be
saved.
Some of the limitations of our study are that it focused on a
single aetiology of sepsis, was conducted in a single centre, and
that data recorded was incomplete. Nonetheless, our findings and
proposed bundles of care are likely to be applicable to all-cause
sepsis, and it adds to the almost non-existent literature on
management and outcomes of severe sepsis in low resource
settings.
We propose that the stepped care bundles described here may
have utility worldwide. Minor points in both bundles could be
individualised, following local surveys of current practice and
resources. Many hospitals in low-middle income countries may not
have adopted the surviving sepsis campaign because they consider
that resources are not available to follow all of the recommenda-
tions in the guidelines. However, many hospitals may be able to
substantially improve sepsis care and patient outcomes by more
consistent or appropriate use of the resources available. Improved
management of severely septic patients in low resource settings
could impact on millions of lives per year. In the absence of data
specific to these settings, our care bundles extrapolate judiciously
from studies performed in high resource regions. While this
approach seems practical and inaction is ethically indefensible,
recently published evidence underscores the necessity of perform-
ing research directly in low resource settings [37]. Perhaps the
Table 3. Initial resuscitation and infection issues in a resource-limited setting.
Recommendation Bundle I: General ward setting Bundle II: ICU setting
Initial evaluation and detection of severe
sepsis in patients with suspected infection
N Determine Glasgow Coma Score, capillary refill N Admit patients with severe sepsis to ICU
N Measure PaO2/FiO2 or SpO2/FiO2 N Perform arterial blood gas and
calculate PaO2/FiO2
N Measure serum creatinine and total bilirubin in addition to
full blood count
N Use point-of-care test to determine lactate level
Fluid resuscitation N Give first iv fluid challenge of 1,000 mL (adults) or
20 ml/kg (children) of crystalloids over 30 minutes
N Obtain central venous access
N Use a combination of mean arterial blood pressure,
urine output, and POC lactate reduction as resuscitation goals
N Include CVP and central venous oxygen
saturation as goal of resuscitation
Diagnosis N Obtain two or more blood cultures, at least one from
venous puncture and one blood culture from each vascular
access device in place for more than 48 hrs
Antibiotic therapy, and source identification
and control
N Begin intravenous antibiotics within the first hour of
recognising severe sepsis
doi:10.1371/journal.pone.0029858.t003
Table 4. Hemodynamic support and adjunctive therapy of severe sepsis in a resource-limited setting.
Recommendation Bundle I: General ward setting Bundle II: ICU setting
Fluid resuscitation N Insert a urinary catheter and monitor urine output every 2 hours N Monitor hourly urine output
N Use an iterative fluid challenge/clinical response technique
Vasopressors and
inotropic therapy
N Administer dopamine peripherally if patient has hypotension
despite meeting fluid resuscitation goals
N Administer dopamine centrally if
patient has hypotension
N Use dobutamine in patients with low cardiac
filling and low cardiac output
Steroids N Consider iv hydrocortisone for adults with septic shock when hypotension
responds poorly to adequate fluid resuscitation and vasopressors
doi:10.1371/journal.pone.0029858.t004
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surrounds the relative benefits of aggressive fluid challenges in the
absence of sophisticated haemodynamic monitoring or readily
available markers of end-organ perfusion. This may be the most
urgent area for clinical research.
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